Medicare Enrolled

Dr. Rashed Alhabshan

Ophthalmology · Corpus Christi, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
5540 SARATOGA BLVD STE 200, Corpus Christi, TX 78413
8007793482
In practice since 2014 (11 years)
NPI: 1811316680 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Alhabshan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alhabshan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Alhabshan

Dr. Rashed Alhabshan is an ophthalmology specialist in Corpus Christi, TX, with 11 years of NPI registration. Based on federal Medicare data, Dr. Alhabshan performed 1,856 Medicare services across 962 unique beneficiaries.

Between the years covered by Open Payments, Dr. Alhabshan received a total of $3,777 from 12 pharmaceutical and/or device companies across 36 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Alhabshan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice ▲ Top 49% volume in TX $3,777 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,856
Medicare services
Top 49% in TX for ophthalmology
962
Unique beneficiaries
$118
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~169 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Retinal imaging (OCT scan) 500 $28 $78
Eye injection for retinal disease 283 $82 $233
Comprehensive eye exam, established patient 239 $78 $246
Compounded drug, not otherwise classified 202 $70 $278
Aflibercept eye injection (Eylea) 152 $698 $1,605
Exam of retinal blood vessels using a special camera after injection of a dye 115 $100 $265
Office visit, established patient (30-39 min) 97 $85 $249
Steroid injection (triamcinolone) 88 $1 $6
Destruction of leaking blood vessels of retina using laser 63 $252 $1,210
Comprehensive eye exam, new patient 40 $88 $291
Retinal photography (fundus photo) 26 $26 $72
Injection of drug or substance into membrane covering eyeball 22 $37 $100
New patient office visit (45-59 min) 16 $105 $323
Office visit, established patient (10-19 min) 13 $40 $110
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,777
Total received (2018-2024)
Avg $630/year across 6 years
Top 30% in TX for ophthalmology
12
Companies
36
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,777 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$318
2023
$320
2021
$95
2020
$107
2019
$1,663
2018
$1,275

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Bausch & Lomb, a division of Bausch Health US, LLC
$1,580
Mallinckrodt Enterprises LLC
$805
Regeneron Pharmaceuticals, Inc.
$400
Astellas Pharma US Inc
$249
Novartis Pharmaceuticals Corporation
$204
Genentech USA, Inc.
$162
Aerie Pharmaceuticals, Inc.
$122
Regeneron Healthcare Solutions, Inc.
$94
Bausch & Lomb Americas Inc.
$78
Alimera Sciences, Inc.
$52
Apellis Pharmaceuticals, Inc.
$16
Mallinckrodt Hospital Products Inc.
$16
Top 3 companies account for 73.7% of total payments
Associated products mentioned in payments ›
ACTHAR · AKREOS AO · BEOVU · EYLEA HD · Iluvien · Izervay · LOTEMAX SM · Rhopressa · STELLARIS · STELLARIS PC · Stellaris · Susvimo · Syfovre · VITESSE · Vabysmo · XIPERE · YUTIQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $204 per 100 Medicare services performed
Looking for an ophthalmology specialist in Corpus Christi?
Compare ophthalmologists in the Corpus Christi area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
26
Per 100K population
7.4
County median income
$66,021
Nearest hospital
CORPUS CHRISTI MEDICAL CENTER,THE
3.4 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Alhabshan is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Alhabshan experienced with retinal imaging (oct scan)?
Based on Medicare claims data, Dr. Alhabshan performed 500 retinal imaging (oct scan) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Alhabshan receive payments from pharmaceutical companies?
Yes. Dr. Alhabshan received a total of $3,777 from 12 companies across 36 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alhabshan's costs compare to other ophthalmologists in Corpus Christi?
Dr. Alhabshan's average Medicare payment per service is $118. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alhabshan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →